Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study - Takeaways - MDSpire

Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study

  • By

  • Theresa Klinger

  • Katharina Müller

  • Ricarda Graf

  • Matthias Augustin

  • Kristina Hagenström

  • June 22, 2026

  • 0 min

Share

  • 1

    Systemic glucocorticosteroids are recommended for short-term use in atopic dermatitis but are often overprescribed in routine care.

  • 2

    Longer duration of systemic glucocorticoid use is associated with increased risks of adverse events in atopic dermatitis patients.

  • 3

    Adverse events linked to prolonged glucocorticoid use include mental disorders, gastrointestinal disorders, osteoporosis, hypertension, and diabetes.

  • 4

    The study found that duration of glucocorticoid exposure has more robust associations with adverse events than cumulative dose.

  • 5

    Future research should focus on identifying critical exposure windows for better detection of adverse event risks in atopic dermatitis.

Original Source(s)

Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study

  • by Theresa Klinger, Katharina Müller, Ricarda Graf, Matthias Augustin, Kristina Hagenström

  • June 22, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.